EIGER BIOPHARMACEUTICALS, INC.
EIGER BIOPHARMACEUTICALS, INC. is a registered legal entity registered in United States under 3168101, and its current status with California Secretary of State — bizfile Online is inactive. The company was incorporated on 12 November 2008 and lists its registered address as PALO ALTO, United States. 5 shareholders are on record for EIGER BIOPHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 5 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for EIGER BIOPHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Ameriprise Financial, Inc., holding 28.6% — the largest recorded stake — followed by Propel Bio Management, LLC at 16.8%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 20 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Ameriprise Financial, Inc. | 28.6% | California Secretary of State — bizfile Online | |
| Propel Bio Management, LLC | 16.8% | California Secretary of State — bizfile Online | |
| Simplify Exchange Traded Fds-Simplify Propel Opportunities ETF | 10.3% | California Secretary of State — bizfile Online | |
| Columbia Fds Ser Tr II-Columbia Seligman Technology & Information Fund | 8.9% | California Secretary of State — bizfile Online | |
| 683 Capital Management LLC | 8% | California Secretary of State — bizfile Online |
Officers
5
The Ceo & Director of EIGER BIOPHARMACEUTICALS, INC. currently on record is David Apelian M.b.a., M.d., Ph.d.; five officers are currently on record for EIGER BIOPHARMACEUTICALS, INC., filed with California Secretary of State — bizfile Online.
The register reports 13 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at EIGER BIOPHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
EIGER BIOPHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 4 subsidiaries span United States, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
EIGER BIOPHARMACEUTICALS, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns EIGER BIOPHARMACEUTICALS, INC.?
Five shareholders are currently on record for EIGER BIOPHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Ameriprise Financial, Inc., holding 28.6% — the largest recorded stake — followed by Propel Bio Management, LLC at 16.8%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is EIGER BIOPHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for EIGER BIOPHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does EIGER BIOPHARMACEUTICALS, INC. have on record?
5 shareholders are shown on record for EIGER BIOPHARMACEUTICALS, INC.. The register reports 20 in total; only the top 5 by holding are shown here.
What is EIGER BIOPHARMACEUTICALS, INC.'s company registration number?
EIGER BIOPHARMACEUTICALS, INC.'s registration number is 3168101, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is inactive.
Is EIGER BIOPHARMACEUTICALS, INC. still an active company?
EIGER BIOPHARMACEUTICALS, INC.'s status on California Secretary of State — bizfile Online is listed as inactive, not currently active.
When was EIGER BIOPHARMACEUTICALS, INC. incorporated?
EIGER BIOPHARMACEUTICALS, INC. was incorporated on 12 November 2008, according to California Secretary of State — bizfile Online.
What is EIGER BIOPHARMACEUTICALS, INC.'s registered address?
The registered address on file for EIGER BIOPHARMACEUTICALS, INC. is PALO ALTO, United States.
Who are the officers/directors of EIGER BIOPHARMACEUTICALS, INC.?
The Ceo & Director of EIGER BIOPHARMACEUTICALS, INC. currently on record is David Apelian M.b.a., M.d., Ph.d.; five officers are currently on record for EIGER BIOPHARMACEUTICALS, INC., filed with California Secretary of State — bizfile Online. Management authority at EIGER BIOPHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does EIGER BIOPHARMACEUTICALS, INC. have a parent company or subsidiaries?
EIGER BIOPHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 2 jurisdictions. Those 4 subsidiaries span United States, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to EIGER BIOPHARMACEUTICALS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to EIGER BIOPHARMACEUTICALS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access EIGER BIOPHARMACEUTICALS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like EIGER BIOPHARMACEUTICALS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 5 October 2026.